RHAMM and ICAM-1 (RHAMM, ICAM-1)

RHAMM (Receptor for hyaluronan mediated motility) and ICAM-1 (Intercellular adhesion molecule 1) are two distinct molecules, not a single target. RHAMM is a multifaceted hyaluronan receptor involved in cell migration, wound healing, and oncogenic processes, with variable subcellular localizations. ICAM-1 is a transmembrane glycoprotein primarily expressed on endothelial cells and leukocytes, playing a central role in immune cell adhesion, transmigration, and serving as a viral entry receptor. While both are involved in processes like inflammation and cancer, they are separate entities with distinct biological functions, structures, and disease roles, and do not form a single molecular complex.

Other names

HMMRHyaluronan-mediated motility receptorCD168CD54ICAM1Cluster of Differentiation 54

Mechanism of action varies by molecule: RHAMM antagonists may block hyaluronan binding or disrupt ERK pathway interactions. ICAM-1 targeting involves inhibition of cell adhesion, blockade of leukocyte recruitment, or viral entry inhibition.